Pharmaids Pharmaceuticals Limited (PHARMAID.BO)
INR 67.79
(5.08%)
INR 67.79
(5.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 37.28 Million INR | 129.24% |
| 2022 | -127.54 Million INR | -3030.3% |
| 2021 | -4.07 Million INR | -103.44% |
| 2020 | -2 Million INR | -819.72% |
| 2019 | -217.76 Thousand INR | 79.98% |
| 2018 | -1.08 Million INR | 53.97% |
| 2017 | -2.36 Million INR | 61.17% |
| 2016 | -6.08 Million INR | -301.42% |
| 2015 | 3.02 Million INR | 185.83% |
| 2014 | 1.05 Million INR | -54.71% |
| 2013 | 2.33 Million INR | -23.0% |
| 2012 | 3.03 Million INR | -42.37% |
| 2011 | 5.26 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -9.3 Million INR | 0.0% |
| 2023 Q1 | - INR | 100.0% |
| 2023 FY | 37.28 Million INR | 129.24% |
| 2023 Q3 | - INR | 100.0% |
| 2023 Q4 | 37.28 Million INR | 0.0% |
| 2022 Q2 | 5.48 Million INR | 0.0% |
| 2022 Q4 | -127.54 Million INR | 0.0% |
| 2022 FY | -127.54 Million INR | -3030.3% |
| 2022 Q1 | - INR | 100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q3 | -818 Thousand INR | 3.54% |
| 2021 FY | -4.07 Million INR | -103.44% |
| 2021 Q2 | -848 Thousand INR | 0.0% |
| 2021 Q1 | - INR | 100.0% |
| 2021 Q4 | -4.07 Million INR | -398.1% |
| 2020 Q3 | -747 Thousand INR | 62.18% |
| 2020 FY | -2 Million INR | -819.72% |
| 2020 Q4 | -2 Million INR | -168.11% |
| 2020 Q2 | -1.97 Million INR | 0.0% |
| 2019 Q2 | -614 Thousand INR | 0.0% |
| 2019 FY | -217.76 Thousand INR | 79.98% |
| 2019 Q4 | -217.76 Thousand INR | -20.98% |
| 2019 Q3 | -180 Thousand INR | 70.68% |
| 2018 Q3 | 213 Thousand INR | 15.76% |
| 2018 Q4 | -1.08 Million INR | -610.8% |
| 2018 FY | -1.08 Million INR | 53.97% |
| 2018 Q1 | -227 Thousand INR | 90.4% |
| 2018 Q2 | 184 Thousand INR | 181.06% |
| 2017 Q2 | -4.07 Million INR | 0.0% |
| 2017 FY | -2.36 Million INR | 61.17% |
| 2017 Q4 | -2.36 Million INR | 0.0% |
| 2016 Q4 | -4.89 Million INR | 0.0% |
| 2016 FY | -6.08 Million INR | -301.42% |
| 2016 Q2 | 3.49 Million INR | 0.0% |
| 2015 FY | 3.02 Million INR | 185.83% |
| 2015 Q4 | 3.02 Million INR | 0.0% |
| 2015 Q2 | 491 Thousand INR | 0.0% |
| 2014 FY | 1.05 Million INR | -54.71% |
| 2014 Q4 | 1.05 Million INR | 0.0% |
| 2014 Q2 | 899 Thousand INR | 0.0% |
| 2013 FY | 2.33 Million INR | -23.0% |
| 2013 Q2 | 2.71 Million INR | 0.0% |
| 2013 Q4 | 2.33 Million INR | 0.0% |
| 2012 FY | 3.03 Million INR | -42.37% |
| 2012 Q4 | 3.03 Million INR | 0.0% |
| 2011 Q4 | 5.31 Million INR | 0.0% |
| 2011 FY | 5.26 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ANG Lifesciences India Limited | 671.01 Million INR | 94.443% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 67.924% |
| Bacil Pharma Limited | 569 Thousand INR | -6453.251% |
| Beryl Drugs Limited | 48.7 Million INR | 23.446% |
| Cian Healthcare Limited | 544.97 Million INR | 93.158% |
| Colinz Laboratories Limited | -64.3 Million INR | 157.988% |
| Concord Drugs Limited | 164.48 Million INR | 77.331% |
| Deccan Health Care Limited | -7.07 Million INR | 626.964% |
| Gennex Laboratories Limited | -552.54 Million INR | 106.748% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | 1.26% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 177.525% |
| Kerala Ayurveda Limited | 447.82 Million INR | 91.674% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 95.955% |
| Mercury Laboratories Limited | -26.72 Million INR | 239.504% |
| Panchsheel Organics Limited | -157.82 Million INR | 123.627% |
| Parmax Pharma Limited | 51.8 Million INR | 28.029% |
| Parnax Lab Limited | 787.61 Million INR | 95.266% |
| Patidar Buildcon Limited | 25.12 Million INR | -48.404% |
| Phaarmasia Limited | -4.89 Million INR | 861.446% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 426.229% |
| Sastasundar Ventures Limited | -297.24 Million INR | 112.544% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 183.56% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 163.647% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 96.438% |
| Sunil Healthcare Limited | 625.4 Million INR | 94.038% |
| Syschem (India) Limited | 3.53 Million INR | -955.719% |
| Trident Lifeline Limited | 117.56 Million INR | 68.282% |
| Transchem Limited | -3.16 Million INR | 1278.881% |
| Tyche Industries Limited | -788.94 Million INR | 104.726% |
| Vikram Thermo (India) Limited | 38.62 Million INR | 3.461% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 148.965% |
| Zenith Healthcare Limited | -25.45 Million INR | 246.474% |
| Zenotech Laboratories Limited | -196.85 Million INR | 118.942% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | -47.89% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 91.363% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 715.517% |
| MedPlus Health Services Limited | 8.67 Billion INR | 99.57% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 143.383% |
| Smruthi Organics Limited | 111.28 Million INR | 66.494% |
| Trimurthi Limited | -1.17 Million INR | 3264.828% |
| Zenlabs Ethica Limited | 139.54 Million INR | 73.279% |
| Makers Laboratories Limited | 172.59 Million INR | 78.395% |
| Lactose (India) Limited | 373.97 Million INR | 90.029% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 94.591% |
| Roopa Industries Limited | 216.01 Million INR | 82.738% |
| PANJON LTD. | -12.8 Million INR | 391.131% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -177.337% |
| Anuh Pharma Limited | -69.8 Million INR | 153.416% |
| Crestchem Limited | -1.45 Million INR | 2671.586% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 161.398% |
| PRAVEG LIMITED | -434.98 Million INR | 108.572% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 96.428% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 154.622% |
| Norris Medicines Limited | 214.86 Million INR | 82.646% |
| Denis Chem Lab Limited | -236.28 Million INR | 115.781% |
| Veerhealth Care Limited | -2.38 Million INR | 1663.438% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 104.709% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 93.473% |
| Godavari Drugs Limited | 530.02 Million INR | 92.965% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 500.516% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 71.773% |
| Vivanza Biosciences Limited | 50.02 Million INR | 25.463% |
| Medi-Caps Limited | -3.21 Million INR | 1260.174% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 140.035% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 81.528% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 169.201% |
| Bharat Parenterals Limited | 1.48 Billion INR | 97.495% |
| BDH Industries Limited | -164.47 Million INR | 122.672% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | 52.622% |
| Coral Laboratories Limited | -612.82 Million INR | 106.085% |
| Evoq Remedies Limited | 41.14 Million INR | 9.381% |
| Trinity League India Limited | -12 Thousand INR | 310833.333% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 97.327% |
| Natural Capsules Limited | 956.68 Million INR | 96.102% |
| Auro Laboratories Limited | 252.51 Million INR | 85.233% |